Research & Development
Boehringer Ingelheim RCV Vienna is home to Boehringer Ingelheim's dedicated drug discovery center for innovative cancer medicines. A team of more than 280 scientists and technicians, combining their expertise in cancer biology and genomics, pharmacology, medicinal chemistry, structural research, screening and discovery ADME, drive our efforts to identify novel medicines for the treatment of cancer. In the Department of Medicinal Chemistry we are currently looking for a highly motivated and result oriented scientist (m/f) with a strong back-ground in synthetic organic chemistry to strengthen our team as a Principal Scientist/Laboratory Head in the Department of Medicinal Chemistry.
The Medicinal Chemistry department and its scientists play an essential role in all phases of drug discovery and contributes to the design and optimisation of novel small molecule based innovative medicines for cancer patients. The adventure of drug discovery includes taking strategic decisions in multidisciplinary project teams and encompasses designing and synthesizing of molecules matching our ambition to drug challenging targets including novel modalities. Team science, agility, accountability and intrapreneurship comprise the skills and mindset of a scientist we would like to welcome in our team.
For this position we offer an interesting salary package considering your expertise and personal competencies as well as your professional experience. We are obliged by law to state the minimum salary according to the collective agreement, which amounts to EUR 48,718.04 gross per year (full-time) for this position, whereby an overpayment is possible. Moreover, we offer our employees a variety of attractive benefits: staff restaurant, pension scheme, comprehensive health promotion and a variety of training opportunities are just a few of them.
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
Your application will be reviewed by our recruiting team as well as the respective department. Therefore, we do not state a specific contact person and kindly ask you to use a general salutation in your application.